Acute myeloid leukemia, version 2.2013 featured updates to the NCCN guidelines

Margaret R. O'Donnell, Martin S. Tallman, Camille N. Abboud, Jessica K. Altman, Frederick R. Appelbaum, Daniel A. Arber, Eyal Attar, Uma Borate, Steven E. Coutre, Lloyd E. Damon, Jeffrey Lancet, Lori J. Maness, Guido Marcucci, Michael G. Martin, Michael M. Millenson, Joseph O. Moore, Farhad Ravandi, Paul J. Shami, B. Douglas Smith, Richard M. StoneStephen A. Strickland, Eunice S. Wang, Kristina M. Gregory, Maoko Naganuma

Research output: Contribution to journalReview article

103 Scopus citations

Abstract

These NCCN Guidelines Insights summarize several key updates to the NCCN Guidelines for Acute Myeloid Leukemia and discuss the clinical evidence that support the recommendations. The updates described in this article focus on the acute promyelocytic leukemia (APL) section, featuring recommendations for additional induction/consolidation regimens in patients with low- or intermediate-risk APL, and providing guidance on maintenance strategies for APL.

Original languageEnglish (US)
Pages (from-to)1047-1055
Number of pages9
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume11
Issue number9
DOIs
StatePublished - Sep 1 2013

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Acute myeloid leukemia, version 2.2013 featured updates to the NCCN guidelines'. Together they form a unique fingerprint.

Cite this